BioSpace News Archive

Business

Endo Reports Second-Quarter 2018 Financial Results

Second-quarter 2018 revenues of $715 million compared to second-quarter 2017 revenues of $876 million

August 8, 2018
·
105 min read
Business

Charles River Laboratories Announces Second-Quarter 2018 Results from Continuing Operations

Second-Quarter Revenue of $585.3 Million

August 8, 2018
·
26 min read
Policy

QUANTM Irradiation System™ Earns CE Mark Approval

First-in-class, advanced technology enables production of high-value radioisotopes on medical cyclotrons.

August 8, 2018
·
2 min read
Business

Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases

Ambys also announced today a strategic partnership with Takeda bringing total committed funding at launch to $140 million.

August 8, 2018
·
4 min read
FDA

Alector Receives Orphan Drug Designation from the U.S. FDA for AL001 for the Treatment of Frontotemporal Dementia

AL001 is a human recombinant monoclonal antibody, for the treatment of all patients with frontotemporal dementia.

August 8, 2018
·
2 min read
Business

Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases

Partnership to support the advancement of the Ambys platform and pipeline.

August 8, 2018
·
5 min read
Business

Rocket Pharmaceuticals Reports Second Quarter 2018 Financial Results and Operational Highlights

Achieved Regulatory Designations for Fanconi Anemia (FA) in the U.S. and Europe; Registrational Trial on Track for 2019

August 8, 2018
·
10 min read
Business

Opening of New Manufacturing Facility to Meet Expanding Demand for Topical Wound Oxygen (TWO2) Therapy Devices

AOTI Inc. announced the opening of an expanded manufacturing facility in Galway, Ireland for the production of its patented Topical Wound Oxygen (TWO2) therapy devices.

August 8, 2018
·
2 min read
Business

Ortho Dermatologics Announces 2018 Aspire Higher Scholarship Recipients

Scholarships Awarded to Nine Students Affected by Dermatologic Conditions

August 8, 2018
·
6 min read
Genetown

Syros to Present at 2018 Wedbush PacGrow Healthcare Conference

Syros Pharmaceuticals announced that its Chief Financial Officer Joseph J. Ferra will present a corporate overview at the 2018 Wedbush PacGrow Healthcare Conference.

August 8, 2018
·
1 min read